Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment-Reference-Cited by-同舟云学术

Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment

Author:

Yang Jia-Sin¹²,Lin Chiao-Wen³⁴,Su Shih-Chi⁵⁶,Yang Shun-Fa¹²

Affiliation:

1. Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan

2. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

3. Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan

4. Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan

5. Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan

6. Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospitals, Linkou, Taiwan

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

Reference99 articles.

1. Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献